Blood tests track lung Cancer's resistance to drugs
NCT ID NCT07475637
Summary
This study looked back at medical records to see how well a simple blood test could detect when lung cancer stops responding to certain drugs. Researchers analyzed data from 70 patients in Tunisia with advanced lung cancer who had developed resistance to their initial treatments. The goal was to understand if repeated blood tests could help guide future treatment decisions by spotting a specific genetic change linked to drug resistance.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON-SMALL CELL LUNG CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Pathology Department, Charles Nicolle Hospital of Tunis
Tunis, 1007, Tunisia
Conditions
Explore the condition pages connected to this study.